DCM
LOXO

Delpha Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Delpha Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-94
Closed -$8K – 1609
2017
Q4 		$8K Buy
+94
New +$7.84K 0.01% 1164

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Delpha Capital Management's LOXO Position: Q1 2018 in Review

Delpha Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2018, closing a stake of 94 shares — an estimated $8K sold.

Delpha Capital Management first reported a position in LOXO in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 158 funds tracked by Wall St. Rank hold LOXO as of Q1 2018.

  • Delpha Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 94 Loxo Oncology, Inc shares in Q1 2018, an estimated $8K.
  • Delpha Capital Management first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Loxo Oncology, Inc position peaked at $8K in Q4 2017.
  • 158 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.